No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection

Apr 4, 2020

No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection

Posted by Nicholi Avery in category: biotech/medical

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.

Copyright © 2020 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.

ScienceDirect ® is a registered trademark of Elsevier B.V.

Comments are closed.

GETAS THREAT LEVEL: ELEVATED
FACEBOOK: 13,950 MEMBERS
LINKEDIN: 2,066 MEMBERS
TWITTER FEED: 31,497 MEMBERS
GETTR FEED: 39,482 MEMBERS

LIFEBOAT NEWS: 3,404 SUBSCRIBERS
GETAS ALERTS: 573 SUBSCRIBERS
BLOG: 122,147 POSTS
DONORS: 6,001

BOARDS: 2,939 MEMBERS
REPORTS: 74
PROGRAMS: 25
FORUMS: 24
QUOTES: 136

FIGHT AIDS: 3 MEMBERS
FOLDING@HOME: 15 MEMBERS
ROSETTA@HOME: 44 MEMBERS

© 2002–2024 Lifeboat Foundation